Gold plunges 5% as stocks soar on COVID-19 vaccine euphoria

By Sumita Layek (Reuters) - Gold slumped more than 5% on Monday as news of the first successful late-stage COVID-19 vaccine trials prompted investors to dump safe-haven bullion and flock to riskier assets. Spot gold was down 5.1% at $1,852.82 per ounce by 11:07 a.m.

Reuters November 10, 2020 00:05:40 IST
Gold plunges 5% as stocks soar on COVID-19 vaccine euphoria

COVID-19 vaccine euphoria" src="https://images.firstpost.com/wp-content/uploads/reuters/11-2020/10/2020-11-09T130235Z_1_LYNXMPEGA80W8_RTROPTP_2_GLOBAL-PRECIOUS.jpg" alt="Gold plunges 5 as stocks soar on COVID19 vaccine euphoria" width="300" height="225" />

By Sumita Layek

(Reuters) - Gold slumped more than 5% on Monday as news of the first successful late-stage COVID-19 vaccine trials prompted investors to dump safe-haven bullion and flock to riskier assets.

Spot gold was down 5.1% at $1,852.82 per ounce by 11:07 a.m. EDT (1607 GMT), while U.S. gold futures slid 4.9% to $1,855.30.

Spot prices beat a sharp retreat from a near two-month peak of $1,965.33 hit earlier in the session amid a weaker dollar and hopes for more stimulus following Joe Biden's victory in the U.S. elections.

Equities surged after Pfizer Inc said its experimental COVID-19 vaccine was more than 90% effective. Pfizer and German partner BioNTech SE said they expect to seek U.S. emergency use authorization later this month.[.N]

"(The news) really exceeded everyone's best-case scenarios. There was growing nervousness that we might not get a strong vaccine result, so this unleashed the risk-on trade and for gold, signalled a massive exodus of safe-haven plays," said Edward Moya, senior market analyst at OANDA.

However, he added "the economy is still in need of much support and only 50 million (vaccine) doses will be available, so we're not in the clear with the virus and the calls for stimulus will be growing."

Bullion, a hedge against currency debasement and inflation, has climbed 24% this year, mainly driven by unprecedented global pandemic-led stimulus.

"If you think that you're living in the best of all worlds, then you don't need gold," said Commerzbank analyst Daniel Briesemann.

"However, this assessment seems to be premature. And we've often seen in the past that at prices below $1,900, buying interest will come into the market - we would expect that to happen again this time."

Other precious metals also sold off, with silver sliding 6.7% to $23.87 per ounce, platinum falling 3.9% to $854.50 and palladium shedding 0.8% to $2,471.32.

(Reporting by Sumita Layek and Asha Sistla in Bengaluru; Editing by Jan Harvey and Chris Reese)

This story has not been edited by Firstpost staff and is generated by auto-feed.

Updated Date:

TAGS:

Find latest and upcoming tech gadgets online on Tech2 Gadgets. Get technology news, gadgets reviews & ratings. Popular gadgets including laptop, tablet and mobile specifications, features, prices, comparison.

also read

U.S. job openings rise slightly in September
Business

U.S. job openings rise slightly in September

WASHINGTON (Reuters) - U.S. job openings increased moderately in September and layoffs appeared to abate, pointing to a gradual labor market recovery from the COVID-19 pandemic.

Central bankers seek new role in brave new world
Business

Central bankers seek new role in brave new world

By Balazs Koranyi and Francesco Canepa FRANKFURT (Reuters) - Taking a break from fighting the coronavirus crisis, the world's top central bankers will attempt to resolve the existential questions of their profession this week as they tune into the European Central Bank's annual policy symposium. Having struggled to lift anaemic inflation for years, officials including the heads of the ECB, the U.S. Federal Reserve and the Bank of England will attempt to figure out why monetary policy is not working as it used to and what new role they must play in a changed world - be it fighting inequality or climate change.

Asian stocks extend gains as vaccine hopes support global reopening
Business

Asian stocks extend gains as vaccine hopes support global reopening

By Lawrence Delevingne BOSTON (Reuters) - Asian shares rose on Wednesday as hopes for a successful coronavirus vaccine lifted expectations of a swift reopening of the global economy, which would help the region's heavily trade-dependent markets.